How to fund research: partial randomisation?

As competition for research funding increases, agencies are looking for novel ways to allocate their funds in a bid to remove potential biases and increase the transparency of how funding decisions are made.

This half-day event from QuantOCancer will highlight examples from international funding entities that are either already piloting or considering implementing different models to allocate research funds with a particular emphasis on the partial randomisation process, and bring the perspective of researchers on this topic.

Speakers will include Marco Bieri from the SNSF Swiss National Science Foundation, Lene B. Oddershede, Professor from the Novo Nordisk Foundation, Axel Philipps from the Leibniz Universität Hannover, and Adrian Mota from the Canadian Institutes of Health Research | Instituts de recherche en santé du Canada, with a researcher roundtable session moderated by Adriana Sánchez-Danés from the Champalimaud Foundation.